Hoffman Reid's Form 4 filing
Vor Biopharma Inc. (VOR) · filed Oct 21, 2025
- Accession no.
- 0002050755-25-000019
- Filed
- Oct 21, 2025, 5:45 PM ET
- Trade date
- Oct 17-21, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $1.13M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman ReidCIK 0001519339 | 10% Owner |
| Reprogrammed Interchange LLCCIK 0002050755 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | Common Stock | SSaleDisposed | −24,689 | $30.22F1 | −$746,118.86 | 1,179,753 | Direct | |
| Oct 17, 2025 | Common Stock | SSaleDisposed | −1,028 | $31.00 | −$31,868 | 1,178,725 | Direct | |
| Oct 20, 2025 | Common Stock | SSaleDisposed | −11,616 | $30.05F3 | −$349,101.46 | 1,167,109 | Direct | |
| Oct 21, 2025 | Common Stock | SSaleDisposed | −200 | $30.08 | −$6,015 | 1,166,909 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.